Astragalus Membranaceus Extract Market, Global Outlook and Forecast 2025-2032

In Business Insights
June 14, 2025

The global Astragalus Membranaceus Extract market demonstrates steady expansion, valued at US$ 21.5 million in 2024 with projections indicating growth to US$ 28.5 million by 2032, reflecting a 3.9% CAGR. This sustained demand stems from escalating applications in nutraceuticals, pharmaceuticals, and functional foods, particularly as aging populations and health-conscious consumers embrace traditional herbal remedies with clinically validated benefits.

Astragalus extract remains prized for its bioactive compounds—polysaccharides and astragalosides—that demonstrate immunomodulatory and cardioprotective properties. As Western markets intensify research into adaptogenic herbs, manufacturers are optimizing extraction techniques to meet pharmaceutical-grade purity standards while maintaining cost competitiveness in supplement formulations.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/294919/global-astragalus-membranaceus-extract-forecast-market-2025-2032-217

Market Overview & Regional Analysis

Asia-Pacific commands 68% of global production, with China dominating cultivation and processing due to millennia-old Traditional Chinese Medicine (TCM) practices. However, North American and European markets exhibit the fastest uptake, fueled by clinical studies validating Astragalus’ efficacy in immune support and anti-aging applications—prompting major supplement brands to reformulate with standardized extracts.

Regulatory harmonization remains fragmented. While the EU’s Traditional Herbal Medicinal Products Directive facilitates entry, the FDA’s DSHEA framework in the U.S. creates formulation constraints. Emerging economies face infrastructure gaps in testing and certification, though Latin America shows promise with growing functional food adoption.

Key Market Drivers and Opportunities

The market thrives on three pillars: validated scientific research on Astragalus’ active constituents (over 2,400 PubMed-listed studies), the global nutraceutical boom projected to exceed $700 billion by 2030, and pharmacological interest in polysaccharides as antiviral agents. Notably, post-pandemic demand for immune-modulating botanicals persists, with Astragalus-containing supplements witnessing 17% year-over-year sales growth in U.S. retail channels.

Opportunities abound in precision fermentation-derived astragalosides for pharmaceutical applications and partnerships with oncology researchers exploring adjunctive chemotherapy support. The sports nutrition sector also presents white space, given emerging data on the extract’s endurance-enhancing properties comparable to Rhodiola rosea.

Challenges & Restraints

Supply chain vulnerabilities persist—climate change impacts root yields in drought-prone cultivation regions, while Chinese export regulations periodically disrupt ingredient flows. Standardization hurdles plague the industry, with HPLC testing revealing 40% variability in astragaloside IV content across commercial extracts. Regulatory scrutiny intensifies, particularly concerning heavy metal contamination and ADA-free processing certifications.

Market Segmentation by Type

  • Astragalus Polysaccharide
  • Astragaloside IV

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/294919/global-astragalus-membranaceus-extract-forecast-market-2025-2032-217

Market Segmentation by Application

  • Healthy Food
  • Pharmaceutical Industry
  • Feed Additives
  • Other

Market Segmentation and Key Players

  • Euromed SA
  • Xi’an Gaoyuan Bio-Chem
  • World-way Biotech
  • Zhe Jiang Skyherb Biotechnology
  • Xinxiang Bokai Biological
  • Acetar Bio-Tech
  • Ningxian hengrui kang biological
  • Shaanxi Jiahe Phytochem
  • Xi’an Rainbow Biotech
  • Xi`an Green Spring Technology
  • Inner Mongolia Ever Brilliance Biotechnology

Report Scope

This report delivers comprehensive analysis of the global Astragalus extract market from 2024-2032, featuring:

  • Volume and revenue forecasts across 25+ countries
  • Granular segmentation by extract type and end-use sectors
  • Pricing analysis including premiumization trends for clinical-grade material

Strategic profiles cover 11 major producers, detailing:

  • Production capacities and CAPEX plans
  • Patent landscapes for proprietary extraction methods
  • Downstream integration into finished formulations

Primary research included interviews with:

  • 22 cultivators across China’s top-producing provinces
  • Regulatory experts from EMA, FDA, and NHCP
  • R&D heads at leading nutraceutical brands

Get Full Report Here: https://www.24chemicalresearch.com/reports/294919/global-astragalus-membranaceus-extract-forecast-market-2025-2032-217

About 24chemicalresearch

Founded in 2015, 24chemicalresearch has rapidly established itself as a leader in chemical market intelligence, serving clients including over 30 Fortune 500 companies. We provide data-driven insights through rigorous research methodologies, addressing key industry factors such as government policy, emerging technologies, and competitive landscapes.

  • Plant-level capacity tracking
  • Real-time price monitoring
  • Techno-economic feasibility studies

With a dedicated team of researchers possessing over a decade of experience, we focus on delivering actionable, timely, and high-quality reports to help clients achieve their strategic goals. Our mission is to be the most trusted resource for market insights in the chemical and materials industries.

International: +1(332) 2424 294 | Asia: +91 9169162030

Website: https://www.24chemicalresearch.com/

Follow us on LinkedIn: https://www.linkedin.com/company/24chemicalresearch